9lione, a Pharmaceutical Distribution DX Company, Raises ¥120 Million in Series A Led by Yokohama Capital

9lione, the operator of the pharmaceutical distribution improvement platform “9lione (Kurione),” announced on the 11th that it has raised ¥120 million in a Series A round led by Yokohama Capital. The total amount raised, including investments and loans from existing investors, has reached ¥440 million. 9lione supplies surplus pharmaceuticals from medical institutions and pharmacies to other medical institutions and pharmacies in need. The company offers the cloud-based pharmaceutical management

NewsBeagle is a discovery engine. We show the headline, a short source-supplied summary and clear attribution. The complete reporting remains with the publisher.